NDC 70518-2442

Lorazepam 1 mg tablet

On the label: Remedyrepack Inc.. It's repackaged: Remedyrepack Inc. rebottles it from Leading Pharma, LLC's NDC 69315-905.

Where the pills inside were made

Recalls

• Jan 21, 2025 · Class II · The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
  Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
  Lots: Lot #s: N01419, N01420, N01421, Exp 03/31/2025; N01663, Exp 06/30/2025; N01664, Exp 08/31/2025; N01673, Exp 09/30/2025; N01688, Exp 08/31/2025; N01747, N01748, N01749, Exp 11/30/2025; N01792, Exp 12/31/2025; N01857, Exp 02/28/2026; N01974, Exp 05/31/2026; N02081, Exp 08/31/2026.
• Sep 28, 2017 · Class II · Leading Pharma, LLC
  Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
  Lots: Lot #E00717

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Lorazepam: every company that makes it

Form

tablet, oral

Strength

1 mg

Approval

ANDA ANDA078203

On the market since

Nov 21, 2019

Package NDCs

70518-2442-0 70518-2442-1 70518-2442-2 70518-2442-3 70518-2442-4 70518-2442-5 70518-2442-6 70518-2442-7

Official label

DailyMed (National Library of Medicine), updated Jul 24, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?